About this medicine
- Approved name
- Iclusig
- International non-proprietary name (INN) or common name
- ponatinib
- Associated names
- Iclusig
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/H/C/2695/A20/0003
- Type
- Article 20 procedures
This type of procedure is triggered for medicines that have been authorised via the centralised procedure in case of quality, safety or efficacy issues.
- Authorisation model
- Centrally authorised product(s)
- Decision making model
- PRAC-CHMP-EC
Key dates and outcomes
- Procedure start date
- 05/12/2013
- PRAC recommendation date
- 09/10/2014
- CHMP opinion date
- 23/10/2014
- EC decision date
- 15/01/2015
- Outcome
- Risk minimisation measures